Evidence map›Paper›PMID 36768836›Full record

ArticleInternational journal of molecular sciences2023

TRPA1 as Target in Myocardial Infarction.

Clara Hoebart, Attila Kiss, Patrick M Pilz, Petra L Szabo, Bruno K Podesser, Michael J M Fischer, Stefan Heber

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Clara HoebartCenter for Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0001-7165-7104
Attila KissCenter for Biomedical Research and Translational Surgery, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-4652-1998
Patrick M PilzCenter for Biomedical Research and Translational Surgery, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0001-6149-8736
Petra L SzaboCenter for Biomedical Research and Translational Surgery, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0001-5465-8391
Bruno K PodesserCenter for Biomedical Research and Translational Surgery, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-4641-7202
Michael J M FischerCenter for Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-3811-7066
Stefan HeberCenter for Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-3398-0442

Funding

FWF Austrian Science Fund P 32534
6 · The paper itself

Abstract

Transient receptor potential cation channel subfamily A member 1 (TRPA1), an ion channel primarily expressed on sensory neurons, can be activated by substances occurring during myocardial infarction. Aims were to investigate whether activation, inhibition, or absence of TRPA1 affects infarcts and to explore underlying mechanisms. In the context of myocardial infarction, rats received a TRPA1 agonist, an antagonist, or vehicle at different time points, and infarct size was assessed. Wild type and TRPA1 knockout mice were also compared in this regard. In vitro, sensory neurons were co-cultured with cardiomyocytes and subjected to a model of ischemia-reperfusion. Although there was a difference between TRPA1 activation or inhibition in vivo, no experimental group was different to control animals in infarct size, which also applies to animals lacking TRPA1. In vitro, survival probability of cardiomyocytes challenged by ischemia-reperfusion increased from 32.8% in absence to 45.1% in presence of sensory neurons, which depends, at least partly, on TRPA1. This study raises doubts about whether TRPA1 is a promising target to reduce myocardial damage within a 24 h period. The results are incompatible with relevant enlargements of infarcts by TRPA1 activation or inhibition, which argues against adverse effects when TRPA1 is targeted for other indications.

Indexed as

Myocardial InfarctionTransient Receptor Potential ChannelsAnimalsMiceMice, KnockoutMyocardiumRatsSensory Receptor CellsTRPA1 Cation ChannelTransient Receptor Potential ChannelsTRPA1 Cation ChannelTrpa1 protein, mouseTrpa1 protein, ratcardiomyocytesischemiareperfusion-injurysensory neurons

Identifiers

PMID36768836
PMCPMC9917254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.